99 related articles for article (PubMed ID: 32892684)
1. Selective inhibition of thromboinflammation in COVID-19 by Btk inhibitors.
Siess W; Hundelshausen PV; Lorenz R
Platelets; 2020 Nov; 31(8):989-992. PubMed ID: 32892684
[No Abstract] [Full Text] [Related]
2. A rationale for blocking thromboinflammation in COVID-19 with Btk inhibitors.
Nicolson PL; Welsh JD; Chauhan A; Thomas MR; Kahn ML; Watson SP
Platelets; 2020 Jul; 31(5):685-690. PubMed ID: 32552307
[No Abstract] [Full Text] [Related]
3. Severe COVID-19 disease and thromboinflammation.
Jerjes-Sánchez C
Arch Cardiol Mex; 2020; 90(3):257-258. PubMed ID: 32952161
[No Abstract] [Full Text] [Related]
4. Platelets and COVID-19: Inflammation, Hyperactivation and Additional Questions.
Koupenova M; Freedman JE
Circ Res; 2020 Nov; 127(11):1419-1421. PubMed ID: 33151798
[No Abstract] [Full Text] [Related]
5. Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19.
Thibaud S; Tremblay D; Bhalla S; Zimmerman B; Sigel K; Gabrilove J
Br J Haematol; 2020 Jul; 190(2):e73-e76. PubMed ID: 32433778
[No Abstract] [Full Text] [Related]
6. Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19).
Thomas LE; Bonow RO; Pencina MJ
JAMA Cardiol; 2020 Sep; 5(9):988-990. PubMed ID: 32936260
[No Abstract] [Full Text] [Related]
7. Potential implications of novel coronavirus disease (COVID-19) related gastrointestinal symptoms for abdominal imaging.
Wilson MP; Katlariwala P; Low G
Radiography (Lond); 2020 Aug; 26(3):274. PubMed ID: 32387085
[No Abstract] [Full Text] [Related]
8. Using the neutrophil-to-lymphocyte ratio to estimate the severity of coronavirus disease 2019.
Kotani K; Morisawa Y; Yamada T
Pol Arch Intern Med; 2020 Aug; 130(7-8):716-717. PubMed ID: 32852911
[No Abstract] [Full Text] [Related]
9. The SARS-CoV-2 N Protein Is a Good Component in a Vaccine.
Ahlén G; Frelin L; Nikouyan N; Weber F; Höglund U; Larsson O; Westman M; Tuvesson O; Gidlund EK; Cadossi M; Appelberg S; Mirazimi A; Sällberg M;
J Virol; 2020 Aug; 94(18):. PubMed ID: 32661140
[No Abstract] [Full Text] [Related]
10. Evaluation of SARS-CoV-2 in the female reproductive tract of COVID-19 patients: A prospective study.
Hu YY; Ji DP; Yu YY; Li YJ; Li B; Hou GH; Zhang XD; Duan CC; Hu RB; Xu J
J Biol Regul Homeost Agents; 2020 Sep-Oct,; 34(5):1885-1888. PubMed ID: 33108863
[No Abstract] [Full Text] [Related]
11. The Impact of COVID-19 on Italy: A Lesson for the Future.
Santacroce L; Bottalico L; Charitos IA
Int J Occup Environ Med; 2020 Jul; 11(3):151-152. PubMed ID: 32225178
[No Abstract] [Full Text] [Related]
12. [Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].
Ding YQ; Bian XW
Zhonghua Bing Li Xue Za Zhi; 2020 Apr; 49(4):291-293. PubMed ID: 32268662
[TBL] [Abstract][Full Text] [Related]
13. Treatments for COVID-19: emerging drugs against the coronavirus.
Khademolhosseini S; Kavandi H; Ghaffari S
Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921740
[TBL] [Abstract][Full Text] [Related]
14. [COVID-19-never waste a crisis?!].
Herold CJ; Delorme S; Weber MA; Reith W; Helmberger T; Reiser M
Radiologe; 2020 Oct; 60(10):891-892. PubMed ID: 32995967
[No Abstract] [Full Text] [Related]
15. Treatments for COVID-19: emerging drugs against the coronavirus - reply.
Potì F
Acta Biomed; 2020 Jun; 91(3):ahead of print. PubMed ID: 32921741
[No Abstract] [Full Text] [Related]
16. Use of statins in patients with COVID-19.
Kow CS; Hasan SS
QJM; 2020 Aug; 113(8):604-605. PubMed ID: 32415971
[No Abstract] [Full Text] [Related]
17. COVID-19: science must not be the boy who cried wolf.
Lewis P; Erren TC
J Epidemiol Community Health; 2020 Aug; 74(8):676. PubMed ID: 32434860
[No Abstract] [Full Text] [Related]
18. The duration of SARS-CoV-2 shedding in patients recovering from COVID-19.
Cimrman Š; Macková L; Král V; Bartoš H; Stiborová I; Dlouhý P
Epidemiol Mikrobiol Imunol; 2020; 69(3):148-151. PubMed ID: 33086857
[TBL] [Abstract][Full Text] [Related]
19. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
Narasaraju T
Ann Intern Med; 2020 Aug; 173(4):323-324. PubMed ID: 32805179
[No Abstract] [Full Text] [Related]
20. Histopathologic Changes and SARS-CoV-2 Immunostaining in the Lung of a Patient With COVID-19.
Zhang H; Wang CY; Zhou P; Yue H; Du R
Ann Intern Med; 2020 Aug; 173(4):324. PubMed ID: 32805177
[No Abstract] [Full Text] [Related]
[Next] [New Search]
